ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,052Medicare Part D Prescriptions Filled, Including Refills

Rank: 116 out of 2429

$636K Total Retail Price of All Prescriptions

Rank: 165 out of 2429

676 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 676 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 11,406 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 887 820 1 1
LEVOTHYROXINE SODIUM 654 586 2 3
METFORMIN HCL 650 583 3 8
OMEPRAZOLE 465 379 4 7
LISINOPRIL 451 418 5 2
HYDROCODONE-ACETAMINOPHEN 260 215 S3 6 6
ALENDRONATE SODIUM 250 235 7 20
LOSARTAN POTASSIUM 238 221 8 22
METOPROLOL SUCCINATE 232 228 9 12
HYDROCHLOROTHIAZIDE 219 210 10 10
METOPROLOL TARTRATE 205 203 11 9
AMLODIPINE BESYLATE 198 177 12 4
FUROSEMIDE 188 171 13 5
FLUTICASONE PROPIONATE 178 125 14 39
BENAZEPRIL HCL 173 162 15 80
ZOLPIDEM TARTRATE 164 146 16 28
IBUPROFEN 162 103 17 57
TRAMADOL HCL 152 128 18 17
ENALAPRIL MALEATE 147 143 19 32
ATORVASTATIN CALCIUM 144 138 20 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 116 21 27
GLIPIZIDE 135 112 22 47
DONEPEZIL HCL 131 131 23 26
DICLOFENAC SODIUM 126 125 24 103
GABAPENTIN 124 107 25 18
AMITRIPTYLINE HCL 123 87 R 26 71
ATENOLOL 123 98 26 15
GLYBURIDE-METFORMIN HCL 122 114 R 28 173
DIOVAN 116 113 29 36
AZITHROMYCIN 114 93 30 46
LOVASTATIN 114 112 30 30
PREDNISONE 111 104 32 38
TAMSULOSIN HCL 111 111 32 29
WARFARIN SODIUM 106 106 34 11
FENOFIBRATE 105 91 35 48
ACTOS 103 103 36 114
SERTRALINE HCL 100 71 37 23
LOSARTAN-HYDROCHLOROTHIAZIDE 94 90 38 73
GLIMEPIRIDE 81 75 39 51
DIOVAN HCT 81 81 39 83
GLYBURIDE 80 79 R 41 64
LANTUS 78 56 42 45
MECLIZINE HCL 77 71 43 131
NEXIUM 77 66 43 37
ACTONEL 77 77 43 188
ADVAIR DISKUS 74 57 46 49
GLIPIZIDE ER 71 61 47 72
DOXAZOSIN MESYLATE 71 71 47 105
CIPROFLOXACIN HCL 69 61 49 84
ISOSORBIDE MONONITRATE ER 65 56 50 55
CARVEDILOL 65 61 50 21
CRESTOR 65 57 50 25
BENAZEPRIL-HYDROCHLOROTHIAZIDE 65 53 50 235
OXYBUTYNIN CHLORIDE ER 64 52 54 79
CLOTRIMAZOLE-BETAMETHASONE 64 48 54 181
RANITIDINE HCL 61 38 56 24
NAPROXEN 61 41 56 75
VENTOLIN HFA 59 46 58 106
AMLODIPINE BESYLATE-BENAZEPRIL 58 45 59 85
FAMOTIDINE 57 52 60 42
NAMENDA 56 56 61 35
PAROXETINE HCL 55 31 62 67
AMOXICILLIN 53 48 63 128
INSULIN SYRINGE 53 38 63 90
CLOPIDOGREL 51 40 65 31
ALLOPURINOL 50 47 66 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.